Literature DB >> 15570119

Whole-spine magnetic resonance imaging in patients with neurofibromatosis type 1 and spinal deformity.

Manoj Ramachandran1, Athanasios I Tsirikos, Joshua Lee, Asif Saifuddin.   

Abstract

OBJECTIVE: Whole-spine magnetic resonance imaging (MRI) has been recommended in the preoperative evaluation of patients with neurofibromatosis type 1 (NF-1). However, no large study has identified the role of MRI in the classification and management of this condition. A retrospective study of 27 patients with NF-1, presenting with spinal deformity, who were investigated with plain radiographs and whole-spine MRI, was conducted to determine the role of whole-spine MRI in the classification and management of patients with NF-1 and spinal deformity.
METHODS: The medical records, radiographs, and MRI studies of 27 neurologically intact patients with NF-1 and spinal deformity, who had been followed for a minimum of 2 years, were reviewed.
RESULTS: The study group comprised 27 patients, 11 of whom were categorized as having nondystrophic and 16 as having dystrophic curves based on radiographic features. All patients had normal neurologic function. In the nondystrophic group, MRI identified dystrophic changes in four patients (associated with a high rate of curve progression in one). A high incidence of intraspinal and paraspinal neurofibromas was documented (overall 37%) in both nondystrophic and dystrophic groups. Significantly more tumors were identified adjacent to the convexity of the curve in the dystrophic group.
CONCLUSION: In a mixed population of pediatric and adult patients with NF-1, normal neurologic function, and spinal deformity, MRI of the whole spine proved useful in the identification of occult vertebral dysplasia and in demonstration of intraspinal and paraspinal neoplasms.

Entities:  

Mesh:

Year:  2004        PMID: 15570119     DOI: 10.1097/01.bsd.0000133466.97241.50

Source DB:  PubMed          Journal:  J Spinal Disord Tech        ISSN: 1536-0652


  10 in total

1.  Whole-body MRI in neurofibromatosis: incidental findings and prevalence of scoliosis.

Authors:  Jacob L Jaremko; Peter J MacMahon; Martin Torriani; Vanessa L Merker; Victor F Mautner; Scott R Plotkin; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2011-12-07       Impact factor: 2.199

2.  Dystrophic thoracic spine dislocation associated with type-1 neurofibromatosis: Case report and rationale for treatment.

Authors:  David Meneses-Quintero; Fernando Alvarado-Gómez; Gabriel Alcalá-Cerra
Journal:  J Craniovertebr Junction Spine       Date:  2015 Apr-Jun

3.  Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.

Authors:  Jean de la Croix Ndong; David M Stevens; Guillaume Vignaux; Sasidhar Uppuganti; Daniel S Perrien; Xiangli Yang; Jeffry S Nyman; Eva Harth; Florent Elefteriou
Journal:  J Bone Miner Res       Date:  2015-01       Impact factor: 6.741

Review 4.  Spinal manifestations of Neurofibromatosis type 1.

Authors:  Ben Shofty; Ori Barzilai; Morsi Khashan; Zvi Lidar; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2020-06-20       Impact factor: 1.475

5.  Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.

Authors:  Wei Zhang; Steven D Rhodes; Liming Zhao; Yongzheng He; Yingze Zhang; Yong Shen; Dalong Yang; Xiaohua Wu; Xiaohong Li; Xianlin Yang; Su-Jung Park; Shi Chen; Charles Turner; Feng-Chun Yang
Journal:  Bone       Date:  2011-03-23       Impact factor: 4.398

6.  Types and prevalence of coexisting spine lesions on whole spine sagittal MR images in surgical degenerative spinal diseases.

Authors:  In-Ho Han; Sang-Hyun Suh; Sung-Uk Kuh; Dong-Kyu Chin; Keun Su Kim
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

7.  Dystrophic spinal deformities in a neurofibromatosis type 1 murine model.

Authors:  Steven D Rhodes; Wei Zhang; Dalong Yang; Hao Yang; Shi Chen; Xiaohua Wu; Xiaohong Li; Xianlin Yang; Khalid S Mohammad; Theresa A Guise; Amanda L Bergner; David A Stevenson; Feng-Chun Yang
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

8.  Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.

Authors:  Christina Bergqvist; Amandine Servy; Laurence Valeyrie-Allanore; Salah Ferkal; Patrick Combemale; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2020-02-03       Impact factor: 4.123

9.  A molecular basis for neurofibroma-associated skeletal manifestations in NF1.

Authors:  Yun Ma; Andrea M Gross; Eva Dombi; Alexander Pemov; Kwangmin Choi; Katherine Chaney; Steven D Rhodes; Steven P Angus; Noah Sciaky; D Wade Clapp; Nancy Ratner; Brigitte C Widemann; Jonathan J Rios; Florent Elefteriou
Journal:  Genet Med       Date:  2020-06-30       Impact factor: 8.864

10.  Orthopaedic manifestations of neurofibromatosis type 1: A case report.

Authors:  Florentina Năstase; Diana Sabina Radaschin; Elena Niculeț; Andrei Vlad Brădeanu; Mădălina Codruța Verenca; Aurel Nechita; Valentin Chioncel; Lawrence Chukwudi Nwabudike; Liliana Baroiu; Eduard Drima Polea; Silvia Fotea; Lucretia Anghel; Alexandru Nechifor; Alin Laurenţiu Tatu
Journal:  Exp Ther Med       Date:  2021-12-13       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.